Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$18.1 million.

  • Maravai Lifesciences Holdings' Free Cash Flow fell 49771.18% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.3 million, marking a year-over-year decrease of 51901.07%. This contributed to the annual value of -$22.2 million for FY2024, which is 13657.93% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Free Cash Flow stood at -$18.1 million, which was down 49771.18% from -$13.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Free Cash Flow ranged from a high of $162.6 million in Q2 2022 and a low of -$20.5 million during Q4 2024
  • Moreover, its 5-year median value for Free Cash Flow was $7.9 million (2024), whereas its average is $45.5 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Free Cash Flow skyrocketed by 178646.56% in 2021 and then tumbled by 49771.18% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Free Cash Flow (Quarter) stood at $53.1 million in 2021, then soared by 75.41% to $93.1 million in 2022, then tumbled by 109.67% to -$9.0 million in 2023, then crashed by 127.41% to -$20.5 million in 2024, then grew by 11.77% to -$18.1 million in 2025.
  • Its Free Cash Flow stands at -$18.1 million for Q3 2025, versus -$13.1 million for Q2 2025 and -$14.6 million for Q1 2025.